When it comes to sizing up pharma’s corporate reputation, U.S. patient groups put GlaxoSmithKline’s ViiV Healthcare, Horizon Therapeutics and Pfizer on top.
The trio nabbed first, second and third places, respectively, among 41 ranked companies in PatientView’s U.S.-only breakdown of its 2021 corporate reputation of pharma survey.